CAAS Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,000
Closed -$4.14M 727
2023
Q2
$4.14M Buy
+25,000
New +$4.03M 0.28% 102
2022
Q3
Sell
-8,100
Closed -$1.44M 915
2022
Q2
$1.44M Buy
+8,100
New +$1.44M 0.07% 303
2021
Q1
Sell
-125,000
Closed -$19.7M 1277
2020
Q4
$19.7M Buy
+125,000
New +$18.4M 0.19% 116

Other funds holding JNJ

CAAS Capital Management's JNJ Position: Q3 2021 in Review

CAAS Capital Management sold out of Johnson & Johnson (JNJ) in Q3 2021, closing a stake of 1,484 shares — an estimated $253K sold.

CAAS Capital Management first reported a position in JNJ in Q2 2020 and held it in 4 quarters. The position peaked at $1.62M in Q2 2020. 3,313 funds tracked by Wall St. Rank hold JNJ as of Q3 2021.

  • CAAS Capital Management reported no remaining Johnson & Johnson position as of Q3 2021 after selling out during the quarter.
  • CAAS Capital Management sold 1,484 Johnson & Johnson shares in Q3 2021, an estimated $253K.
  • CAAS Capital Management first reported a position in Johnson & Johnson in Q2 2020 and held it in 4 quarters.
  • CAAS Capital Management's Johnson & Johnson position peaked at $1.62M in Q2 2020.
  • 3,313 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2021.

Based on CAAS Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.